Optalert sets sights on new software solutions

Wearable technology company Optalert has announced they are developing an exciting new Android app that will put an end to drowsy driving.

Optalert CEO Scott Coles said the Android app will be available by the end of 2015 and will open a whole new world for Optalert.

“When paired with Optalert’s glasses technology, the new Android app will provide users with the opportunity to precisely measure their drowsiness levels using their own Android-based phone.” Mr Coles said.

“This will mean product costs will likely decrease and product availability will increase exponentially translating to many more lives being saved.

“Optalert’s technology picks up on the physiological warning signs of very early onset drowsiness, often well in advance of a person feeling the effects, and translates them into a score using the patented Johns Drowsiness Scale (JDS™).

“Drowsiness is estimated to be a factor in 30% of vehicle crashes worldwide, and this Android app, followed soon after by an Apple app, will be important for both industrial and consumer markets.

“In recent months we have been approached by several global telematics, automotive and phone manufacturers interested in our technology, and of course, we are always interested in talking to companies who would like a competitive edge in the market place.”

The JDS™, named after Optalert Founding Director Dr Murray Johns, was originally developed for use with Optalert technology. Recently, the company’s research and development teams have been successfully applying the technology to other platforms.

“Over the past 12 months we have been developing wireless glasses for customers in the mining and transportation industries and they are in the final stages of testing,” he said.

“This Android app signifies the next great step for our company and proves the power and high demand of our drowsiness algorithms in the growing wearable technology market.”

About Optalert

Optalert is a world-leading wearable technology company focused on the monitoring of real-time individual alertness to combat the risk of fatigue-related accidents.

Using the patented JDS™, Optalert’s early-warning drowsiness detection products assess the user’s drowsiness level in real time by measuring eyelid blinks more than 500 times a second.

Optalert launched their first commercial products in 2008, and since then the company has continually redefined and improved their software and hardware to preempt market demands. The company has achieved 100 percent revenue growth over the past 2014/2015 financial year setting it up for strong continued future growth.

For enquiries contact:         info@optalert.com